FGF-1 reverts epithelial-mesenchymal transition induced by TGF-beta 1 through MAPK/ERK kinase pathway

DSpace/Manakin Repository

Show simple item record Ramos, C Becerril, C Montano, M Ramirez, R Checa, M Selman, M García-De-Alba, C Pardo-Cemo, Annie 2011-01-21T10:35:23Z 2011-01-21T10:35:23Z 2010
dc.identifier.issn 10400605
dc.identifier.uri http://hdlhandlenet/123456789/198
dc.description.abstract doi:10.1152/ajplung.00070.2010.-Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease characterized by the expansion of the fibroblast/myofibroblast population and aberrant remodeling. However, the origin of mesenchymal cells in this disorder is still under debate. Recent evidence indicates that epithelial-mesenchymal transition (EMT) induced primarily by TGF-beta 1 plays an important role en_US
dc.description.abstract however, studies regarding the opposite process, mesenchymal-epithelial transition, are scanty. We have previously shown that fibroblast growth factor-1 (FGF-1) inhibits several profibrogenic effects of TGF-beta 1. In this study, we examined the effects of FGF-1 on TGF-beta 1-induced EMT. A549 and RLE-6TN (human and rat) alveolar epithelial-like cell lines were stimulated with TGF-beta 1 for 72 h, and then, in the presence of TGF-beta 1, were cultured with FGF-1 plus heparin for an additional 48 h. After TGF-beta 1 treatment, epithelial cells acquired a spindle-like mesenchymal phenotype with a substantial reduction of E-cadherin and cytokeratins and concurrent induction of alpha-smooth muscle actin measured by real-time PCR, Western blotting, and immunocytochemistry. FGF-1 plus heparin reversed these morphological changes and returned the epithelial and mesenchymal markers to control levels. Signaling pathways analyzed by selective pharmacological inhibitors showed that TGF-beta 1 induces EMT through Smad pathway, while reversion by FGF-1 occurs through MAPK/ERK kinase pathway, resulting in ERK-1 phosphorylation and Smad2 dephosphorylation. These findings indicate that TGF-beta 1-induced EMT is reversed by FGF-1 and suggest therapeutic approaches to target this process in IPF. en_US
dc.description.abstract Ramos C, Becerril C, Montano M, García-De-Alba C, Ramirez R, Checa M, Pardo A, Selman M. FGF-1 reverts epithelial-mesenchymal transition induced by TGF-beta 1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell Mol Physiol 299: L222-L231, 2010. First published May 21, 2010 en_US
dc.language.iso en en_US
dc.title FGF-1 reverts epithelial-mesenchymal transition induced by TGF-beta 1 through MAPK/ERK kinase pathway
dc.type Artículo de investigación en_US
dc.identifier.idprometeo 118
dc.identifier.doi 10.1152/ajplung.00070.2010
dc.source.novolpages 299(2)
dc.subject.wos Physiology
dc.subject.wos Respiratory System
dc.description.index WoS: SCI, SSCI o AHCI
dc.subject.keywords pulmonary fibrosis
dc.subject.keywords mesenchymal-epithelial transition
dc.subject.keywords Smad2
dc.relation.journal American Journal of Physiology-Lung Cellular and Molecular Physiology
dc.description.Departamento Departamento de Biología Comparada

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account